TSE:LABS MediPharm Labs (LABS) Stock Forecast, Price & News C$0.07 0.00 (0.00%) (As of 06/6/2023 ET) Add Compare Share Share Today's RangeC$0.07▼C$0.0850-Day RangeC$0.07▼C$0.1052-Week RangeC$0.06▼C$0.10Volume67,972 shsAverage Volume183,225 shsMarket CapitalizationC$27.31 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileProfileChartCompetitorsInsider TradesHeadlinesSocial MediaProfileChartCompetitorsInsider TradesHeadlinesSocial Media About MediPharm Labs (TSE:LABS) StockMediPharm Labs Corp., a pharmaceutical company, produces and sells pharmaceutical-quality cannabis oil and concentrates, and advanced derivative products in Canada, Australia, Germany, and internationally. It formulates, processes, packages, and distributes cannabis extracts and advanced cannabinoid-based products. The company also provides GMP flower sourcing, packaging, and distribution services. MediPharm Labs Corp. was founded in 2015 and is headquartered in Barrie, Canada.Read More Receive LABS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for MediPharm Labs and its competitors with MarketBeat's FREE daily newsletter. Email Address LABS Stock News HeadlinesMay 22, 2023 | theglobeandmail.comClosing Bell: Medipharm Labs Corp down on Friday (LABS)May 15, 2023 | msn.comMediPharm Labs Corp. Q1 Revenue Grows 20% YoY, Achieves First Quarter Of Positive Adjusted EBITDAJune 7, 2023 | UNKNOWN (Ad)This NASDAQ Stock Is The Amazon Of Medical SupplyThis Little Known Company IS Quickly Becoming The Amazon Of Medical Supply. Learn More NowMay 15, 2023 | finance.yahoo.comMediPharm Labs Reports First Quarter Results with Growth in Sales, Margin and EBITDAApril 19, 2023 | theglobeandmail.comClosing Bell: Medipharm Labs Corp up on Tuesday (LABS)April 17, 2023 | finance.yahoo.comMarket Participants Recognise MediPharm Labs Corp.'s (TSE:LABS) Revenues Pushing Shares 27% HigherApril 15, 2023 | theglobeandmail.comClosing Bell: Medipharm Labs Corp up on Friday (LABS)April 13, 2023 | theglobeandmail.comClosing Bell: Medipharm Labs Corp flat on Wednesday (LABS)June 7, 2023 | Behind the Markets (Ad)[BREAKING] Pentagon to Spend Billions on "Living Missile"Air Force Magazine calls it "transformational." The Wall Street Journal calls it one of the Pentagon's "highest priorities." National Defense Magazine reports "Eye-popping budget" for it. This small company won the first contract to build them!April 13, 2023 | msn.comMediPharm to cut ~30% staff amid restructuringApril 10, 2023 | theglobeandmail.comClosing Bell: Medipharm Labs Corp flat on Monday (LABS)April 8, 2023 | theglobeandmail.comClosing Bell: Medipharm Labs Corp WT flat on Thursday (LABS-WT)April 7, 2023 | theglobeandmail.comClosing Bell: Medipharm Labs Corp flat on Thursday (LABS)April 6, 2023 | theglobeandmail.comClosing Bell: Medipharm Labs Corp WT flat on Friday (LABS-WT)April 2, 2023 | seekingalpha.comMediPharm Labs reports Q4 resultsMarch 31, 2023 | finance.yahoo.comMediPharm Labs Reports Fourth Quarter and Full Year 2022 ResultsMarch 24, 2023 | ca.finance.yahoo.comStocks in play: VIVO Cannabis Inc.March 6, 2023 | finance.yahoo.comIIROC Trading Halt - LABS.WTFebruary 21, 2023 | finance.yahoo.comMediPharm Labs Corp. Announces Mailing and Filing of Joint Circular for Special Meeting of Shareholders to approve Arrangement with VIVO Cannabis Inc.December 22, 2022 | marketwatch.comMediPharm Labs to Buy Vivo CannabisDecember 22, 2022 | msn.comMediPharm Labs to acquire VIVO Cannabis in all-equity transactionNovember 16, 2022 | finance.yahoo.comMediPharm Labs Third Quarter 2022 Earnings: Revenues Beat Expectations, EPS LagsOctober 7, 2022 | ca.finance.yahoo.comStocks in play: MediPharm Labs CorpAugust 15, 2022 | seekingalpha.comMediPharm Labs Corp. (MEDIF) CEO David Pidduck on Q2 2022 Results - Earnings Call TranscriptJuly 13, 2022 | seekingalpha.comMediPharm Labs enters $6.2M for the sale of Australian facilityJuly 11, 2022 | finance.yahoo.comMediPharm Labs Enters into $6.2M Purchase Agreement for the Sale of Australian FacilityJune 30, 2022 | finance.yahoo.comMediPharm Labs Announces Voting Results From the 2022 Annual Meeting of ShareholdersSee More Headlines LABS Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Industry, Sector and Symbol Stock ExchangeTSE Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A SectorMedical Current SymbolTSE:LABS CUSIPN/A CIKN/A Webwww.medipharmlabs.com Phone705 719 7425FaxN/AEmployees190Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)C($0.11) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeC$-25,610,000.00 Net Margins-110.97% Pretax MarginN/A Return on Equity-39.46% Return on Assets-19.80% Debt Debt-to-Equity Ratio0.41 Current Ratio5.30 Quick Ratio3.10 Sales & Book Value Annual SalesC$23.08 million Price / Sales1.18 Cash FlowC$0.05 per share Price / Cash Flow1.30 Book ValueC$0.19 per share Price / Book0.37Miscellaneous Outstanding Shares390,100,000Free FloatN/AMarket CapC$27.31 million OptionableNot Optionable Beta1.16 Key ExecutivesMr. Keith StrachanCo-Founder & PresMr. Greg HunterChief Financial OfficerMr. David A. PidduckCEO & DirectorMr. Patrick McCutcheonFounderMr. Saravan SubramaniamVP of Operations & Supply ChainMr. Geoffrey MarrExec. VP & Gen. CounselMr. Brett MoonVP of SalesMr. Kirk BinnsExec. VP of Global AccountsMr. Nigel DewsburyHead of QualityMore ExecutivesKey CompetitorsMeta GrowthCVE:METAInMed PharmaceuticalsTSE:INZomedica Pharmaceuticals Corp. (ZOM.V)CVE:ZOMViridium Pacific GroupCVE:VIR48North CannabisCVE:NRTHView All Competitors LABS Stock - Frequently Asked Questions How have LABS shares performed in 2023? MediPharm Labs' stock was trading at C$0.07 on January 1st, 2023. Since then, LABS stock has increased by 0.0% and is now trading at C$0.07. View the best growth stocks for 2023 here. What other stocks do shareholders of MediPharm Labs own? Based on aggregate information from My MarketBeat watchlists, some companies that other MediPharm Labs investors own include Cronos Group (CRON), Aurora Cannabis (ACB), Village Farms International (VFF), Canopy Growth (WEED), Aphria (APHA), Cresco Labs (CRLBF), HEXO (HEXO), Heat Biologics (HTBX), Absolute Software Co. (ABT.TO) (ABT) and Acasti Pharma (ACST). What is MediPharm Labs' stock symbol? MediPharm Labs trades on the Toronto Stock Exchange (TSX) under the ticker symbol "LABS." How do I buy shares of MediPharm Labs? Shares of LABS stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. What is MediPharm Labs' stock price today? One share of LABS stock can currently be purchased for approximately C$0.07. How much money does MediPharm Labs make? MediPharm Labs (TSE:LABS) has a market capitalization of C$27.31 million and generates C$23.08 million in revenue each year. The company earns C$-25,610,000.00 in net income (profit) each year or C($0.11) on an earnings per share basis. How many employees does MediPharm Labs have? The company employs 190 workers across the globe. How can I contact MediPharm Labs? The official website for the company is www.medipharmlabs.com. The company can be reached via phone at 705 719 7425. This page (TSE:LABS) was last updated on 6/7/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MediPharm Labs Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.